Inflammation has long been portrayed as something inherently bad; a process that needs to be fought or suppressed. In popular ...

Discusses Immunology Portfolio Update and Advances in Autoimmune Therapies October 30, 2025 11:30 AM EDTCompany ...

Lung06 Phase 3 Trial of ENHERTU Initiated as First-Line Therapy in Patients with HER2 Overexpressing Metastatic NSCLC ...

Three immunologists have won the 2025 Nobel Prize in Physiology or Medicine for uncovering how the immune system prevents itself from attacking the body.

Mitochondrial dysfunction triggered by ER stress was found to make Tregs unstable and to cause them to lose their protective ...

In the weeks following a bout of influenza or COVID, the risk of heart attack or stroke may rise dramatically, and chronic ...

A new analysis estimates that the asteroid belt is steadily losing mass each year, and may not be as permanent a feature of the solar system as we thought. A team of astronomers led by Julio Fernández ...

Robert Kelly is managing director of XTS Energy LLC, and has more than three decades of experience as a business executive. He is a professor of economics and has raised more than $4.5 billion in ...

Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today that the U.S. Food and Drug Administration (FDA) has approved Gazyva® (obinutuzumab) for the treatment of adult ...

An international study led by experts at the University of Sydney and the Universidad Europea in Spain has found that longer ...

FDA-Registered Home Laser Technology Gains Rapid Adoption During Winter Season as Year-End HSA/FSA Deadlines Drive 290% Search Surge-Podiatrists Report Clinical-Grade Results Without $2,500+ Professio ...

Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced landmark results demonstrating ...